Simon Corcos, at Bradford Teaching Hospitals' HIV Clinic, has seen patients' outcomes transformed.

Around 78% of people who are living with HIV take a daily pill to manage their infection. These drugs work by preventing the ...

The tissue microenvironments surrounding HIV-infected immune cells look a lot like those surrounding cancerous tumors, ...

The first ever weekly oral therapy for the treatment of HIV could offer welcome relief from the burden of lifelong daily pill ...

A review of non-vaccine HIV interventions highlights the strong preventive effects of long-acting PrEP, sustained ART, U=U, ...

Prevention integration improved early HIV detection among women of reproductive age and supported stronger primary care ...

Gilead Sciences’ HIV prevention business reached a milestone, exceeding $1 billion in quarterly sales for the first time. | ...

A new biostatistical modeling approach has the potential to support health decisions by pinpointing where HIV is concentrated ...

A once-weekly HIV pill combining the antiretroviral drugs islatravir and lenacapavir is as effective as a widely used ...

In closing out the TDF/TAF litigation chapter, Gilead is simultaneously moving to a new era of HIV treatment altogether with ...

The biopharmaceutical company lowered its full-year forecast for Veklury after sales of the Covid-19 treatment fell 81% in ...